Oxford COVID-19 Vaccine Trial Results Blended

Oxford COVID-19 Vaccine Trial Results Blended

Editor’s drawl: Bag the latest COVID-19 data and steerage in Medscape’s Coronavirus Resource Heart. Fragment 3 meantime trial outcomes from the Oxford/AstraZeneca vaccine win simply been published in The Lancet. Previously, meantime outcomes had been issued in a press release. In this day’s…

Joe Biden’s Fractured Foot

Joe Biden’s Fractured Foot

President-elect Joe Biden and his transition team are disturbing at work so that they are going to “hit the bottom running” when he is sworn in on January 20th. But in a literal sense, this is able to possibly maybe…

Fixed-Length Ibrutinib-Venetoclax Promising in First-Line CLL

Fixed-Length Ibrutinib-Venetoclax Promising in First-Line CLL

A mounted-duration, first-line combination of ibrutinib (Imbruvica) plus venetoclax (Venclexta) looked doubtless for chronic lymphocytic leukemia (CLL) patients who accomplished undetectable minimal residual disease (MRD) space, outcomes of the randomized CAPTIVATE see confirmed. With a median follow-up of 16.6 months,…